Innate Pharma Posts GAAP EPS -€0.55, Revenue €9.01M Innate Pharma reported GAAP EPS of -€0.55 and revenue €9.01M on Mar 26, 2026 (Seeking Alpha). Immediate focus: cash runway, milestone timing, and clinical catalysts.

Innate Pharma Posts GAAP EPS -€0.55, Revenue €9.01M: Innate Pharma reported GAAP EPS of -€0.55 and revenue €9.01M on Mar 26, 2026 (Seeking Alpha). Immediate focus: cash runway, milestone timing, and… 👈 Read full analysis #InnatePharma #GAAPEPS #RevenueReport #ClinicalTrials #FinancialAnalysis